anti glp 1 antibody Anti-GLP-1R [EPR21819]. Rabbit Monoclonal (ab218532) Rabbit Recombinant Monoclonal GLP Anti-GLP1 antibody [49] (GTX60953) |

Serious adverse effects are uncommon but possible, including allergic reactions, severe injection site reactions if improper technique is used, and excessive detoxification responses in susceptible individuals

10.1152/ajpcell.1983.245.3.C235 139 HaffnerS

Toxicity from anticholinergic drugs are common enough that clinicians use a well-known mnemonic to recognize its symptoms: blind as a bat (blurred vision), dry as a bone (severe dryness), full as a flask (urinary retention), hot as a hare (elevated body temperature), red as a beet (flushed skin), mad as a hatter (vivid, often easily describable hallucinations), and tacky as a leisure suit (referring to tachycardia, a dangerously fast heart rate)

Myles BH, Wei C, Komaki R, Vaporciyan AA, Mehran RJ, SG &, Hofstetter WL, Ajani JA, Liao ZX, Cox JD, Lin SH

Glutathione and Citrulline Supplement Market Analysis Size, Share, and Forecast Outlook 2025 to 2035 Industry Size (2025): USD 760.0 Mn Forecast (2035): USD 1426.6 Mn CAGR (2025 to 2035): 6.5% Glutathione and Citrulline Supplement Market Forecast and Outlook 2025 to 2035 Global glutathione and citrulline supplement market is projected to reach USD 1,426.6 million by 2035, reflecting an absolute increase of USD 666.6 million from its 2025 valuation of USD 760.0 million